Cargando…

Correction to: Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes

Detalles Bibliográficos
Autores principales:	Pison, Christophe, Shah, Pallav L., Slebos, Dirk‑Jan, Ninane, Vincent, Janssens, Wim, Perez, Thierry, Kessler, Romain, Deslee, Gaetan, Garner, Justin L., Hartman, Jorine E., Degano, Bruno, Mayr, Anna, Mayse, Martin, Peterson, Alexander D., Valipour, Arschang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7962218/ https://www.ncbi.nlm.nih.gov/pubmed/33722230 http://dx.doi.org/10.1186/s12931-021-01678-z

Ejemplares similares

Safety of denervation following targeted lung denervation therapy for COPD: AIRFLOW-1 3-year outcomes
por: Christophe, Pison, et al.
Publicado: (2021)

Long-term safety of bilateral targeted lung denervation in patients with COPD
por: Valipour, Arschang, et al.
Publicado: (2018)

Two-Year Outcomes for the Double-Blind, Randomized, Sham-Controlled Study of Targeted Lung Denervation in Patients with Moderate to Severe COPD: AIRFLOW-2
por: Valipour, Arschang, et al.
Publicado: (2020)

Design for a multicenter, randomized, sham-controlled study to evaluate safety and efficacy after treatment with the Nuvaira® lung denervation system in subjects with chronic obstructive pulmonary disease (AIRFLOW-3)
por: Slebos, Dirk-Jan, et al.
Publicado: (2020)

Targeted lung denervation for moderate to severe COPD: a pilot study
por: Slebos, Dirk-Jan, et al.
Publicado: (2015)

Targeted lung denervation modulates the mucosal epithelial transcriptome in COPD
por: Srikanthan, Karthi, et al.
Publicado: (2022)

Safety and Adverse Events after Targeted Lung Denervation for Symptomatic Moderate to Severe Chronic Obstructive Pulmonary Disease (AIRFLOW). A Multicenter Randomized Controlled Clinical Trial
por: Slebos, Dirk-Jan, et al.
Publicado: (2019)

Bronchoscopic Lung Volume Reduction Coil Treatment for Severe Emphysema: A Systematic Review and Meta-Analysis of Individual Participant Data
por: Roodenburg, Sharyn A., et al.
Publicado: (2022)

Targeted lung denervation in sheep: durability of denervation and long-term histologic effects on bronchial wall and peribronchial structures
por: Mayse, Martin L., et al.
Publicado: (2020)

Physiologic and histopathologic effects of targeted lung denervation in an animal model
por: Hummel, James P., et al.
Publicado: (2019)

Delay of airway epithelial wound repair in COPD is associated with airflow obstruction severity
por: Perotin, Jeanne-Marie, et al.
Publicado: (2014)

New bronchoscopic treatment modalities for patients with chronic bronchitis
por: Hartman, Jorine E., et al.
Publicado: (2021)

Renal Denervation in Asia: Consensus Statement of the Asia Renal Denervation Consortium
por: Kario, Kazuomi, et al.
Publicado: (2020)

Effects of Renal Denervation Documented in the Austrian National Multicentre Renal Denervation Registry
por: Zweiker, David, et al.
Publicado: (2016)

A prospective safety and feasibility study of metered cryospray for patients with chronic bronchitis in COPD
por: Garner, Justin L., et al.
Publicado: (2020)

2013: The Year of Renal Denervation?
por: Menown, Ian B. A.
Publicado: (2013)

Renal denervation: back on track
por: Kiuchi, Márcio Galindo
Publicado: (2018)

Cardiac Sympathetic Denervation in Channelopathies
por: Dusi, Veronica, et al.
Publicado: (2019)

Renal denervation: An uncertain future
por: Sever, Peter
Publicado: (2020)

Editorial comment: Renal denervation
por: Schmieder, Roland E., et al.
Publicado: (2021)

The progress of pulmonary artery denervation
por: Xie, Yonghui, et al.
Publicado: (2022)

Renal Sympathetic Denervation for Hypertension
por: Guber, Kenneth, et al.
Publicado: (2022)

Selective denervation for cervical dystonia
por: Bauman, Megan M. J., et al.
Publicado: (2023)

Renal denervation for uncontrolled hypertension
por: Marcusohn, Erez, et al.
Publicado: (2023)

Cytokine responses during chronic denervation
por: Ruohonen, Saku, et al.
Publicado: (2005)

Autonomic Denervation for the Treatment of Atrial Fibrillation
por: Katritsis, Demosthenes G
Publicado: (2011)

Renal denervation as an option for the management of hypertension
por: Santiapillai, Georgina Radhini, et al.
Publicado: (2014)

Expanded indications for transcatheter renal denervation
por: Fronczak, Aneta, et al.
Publicado: (2013)

Renal denervation – current evidence and perspectives
por: Warchoł-Celińska, Ewa, et al.
Publicado: (2013)

Renal denervation for the management of resistant hypertension
por: Patel, Hitesh C, et al.
Publicado: (2015)

Renal Denervation to Treat Cardiac Fibrosis?
por: Wehner, Paulette, et al.
Publicado: (2014)

Renal denervation: a glimpse of hope?
por: Voskuil, M.
Publicado: (2017)

Renal denervation: are we at a crossroads?
por: Voskuil, M.
Publicado: (2016)

Acute hemodynamics of cardiac sympathetic denervation
por: Sinkar, Kunal, et al.
Publicado: (2020)

Renal Denervation, Come Back Time?
por: Jo, Sang-Ho
Publicado: (2020)

Current status of pulmonary artery denervation
por: Davies, Mark G., et al.
Publicado: (2022)

Renal denervation and long-term results
por: Simonetti, Fiorenzo, et al.
Publicado: (2023)

Validation of targeted microsurgical spermatic cord denervation: comparison of outcomes to traditional complete microsurgical spermatic cord denervation
por: Kavoussi, Parviz K
Publicado: (2019)

Does complete renal denervation translate into superior clinical outcomes? Lessons learned from denervation of accessory renal arteries
por: Mendelsohn, Farrell O.
Publicado: (2014)

The effect of renal denervation in an experimental model of chronic renal insufficiency, The REmnant kidney Denervation In Pigs study (REDIP study)
por: Lubanda, Jean-Claude, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_heb1galj6ojubjisj8ev7bb2rp